Clinical guidelines: Secondary prevention of gastric cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Gastric cancer secondary prevention in dyspeptic patients.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
   Article
2. The application of experimental models for the drug discovery for digestive tumors.Molecular cancer · 2026
   Review
3. Identification and validation of serum MUC17 as a non-invasive early warning biomarker for screening of gastric intraepithelial neoplasia.Translational oncology · 2025
   Article
4. Integrated analysis of disulfidoptosis-related genes identifies NRP1 as a novel biomarker promoting proliferation of gastric cancer via glutamine mediated energy metabolism.Discover oncology · 2024
   Article
5. PPIs and gastric cancer: any causal relationship?Acta bio-medica : Atenei Parmensis · 2023
   Article
6. Risk management and healthcare policy · 2022
   Article
7. Gastritis: update on etiological features and histological practical approach.Pathologica · 2020
   Review
8. Ulk1 over-expression in human gastric cancer is correlated with patients' T classification and cancer relapse.Oncotarget · 2017
   Article
9. AMPKα phosphatase Ppm1E upregulation in human gastric cancer is required for cell proliferation.Oncotarget · 2017
   Article
10. Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis.Oncotarget · 2016
    Article
11. Autoimmune gastritis: Pathologist's viewpoint.World journal of gastroenterology · 2015
    Review
12. The stomach in health and disease.Gut · 2015
    Review
13. Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
14. High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2014
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as